These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1349371)

  • 1. Screening for colorectal cancer by stool DNA analysis.
    Lancet; 1992 May; 339(8802):1141-2. PubMed ID: 1349371
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular stool screening for colorectal cancer.
    Mak T; Lalloo F; Evans DG; Hill J
    Br J Surg; 2004 Jul; 91(7):790-800. PubMed ID: 15227685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer screening using stool DNA analysis in clinical practice: early clinical experience with respect to patient acceptance and colonoscopic follow-up of abnormal tests.
    Berger BM; Schroy PC; Rosenberg JL; Lai-Goldman M; Eisenberg M; Brown T; Rochelle RB; Billings PR
    Clin Colorectal Cancer; 2006 Jan; 5(5):338-43. PubMed ID: 16512992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of colorectal cancer by a quantitative fluorescence determination of DNA amplification in stool.
    Calistri D; Rengucci C; Lattuneddu A; Francioni G; Polifemo AM; Nanni O; Saragoni L; Monti F; Ravaioli A; Zoli W; Amadori D
    Neoplasia; 2004; 6(5):536-40. PubMed ID: 15548362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fecal DNA analysis--future method for colorectal cancer screening?].
    Olsson L
    Lakartidningen; 2004 Nov; 101(47):3762-5. PubMed ID: 15609528
    [No Abstract]   [Full Text] [Related]  

  • 6. Fecal-based DNA assays: a new, noninvasive approach to colorectal cancer screening.
    Deenadayalu VP; Rex DK
    Cleve Clin J Med; 2004 Jun; 71(6):497-503. PubMed ID: 15242305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis of malignant colorectal neoplasms by means of molecular genetic analysis of fecal DNA].
    Lantsov VA; Vostriukhina OA
    Vopr Onkol; 2005; 51(2):167-72. PubMed ID: 16222995
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel methylation panel for the early detection of colorectal tumors in stool DNA.
    Azuara D; Rodriguez-Moranta F; de Oca J; Soriano-Izquierdo A; Mora J; Guardiola J; Biondo S; Blanco I; Peinado MA; Moreno V; Esteller M; Capellá G
    Clin Colorectal Cancer; 2010 Jul; 9(3):168-76. PubMed ID: 20643622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stool-based DNA tests for colorectal cancer: clinical potential and early results.
    Ahlquist DA
    Rev Gastroenterol Disord; 2002; 2 Suppl 1():S20-6. PubMed ID: 12439395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Colorectal exfoliated cell in stool and its nuclear DNA quantitative analysis for diagnosis of colorectal cancer].
    Fan RY; Li SR; Wu ZT; Wu X; Chen ZM
    Ai Zheng; 2002 Jul; 21(7):776-80. PubMed ID: 12479106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stool DNA: a viable option for colorectal cancer screening.
    Hardison DM; Shuber AP
    Gastroenterology; 2005 Dec; 129(6):2128-9; author reply 2129. PubMed ID: 16344091
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries.
    Wu GH; Wang YM; Yen AM; Wong JM; Lai HC; Warwick J; Chen TH
    BMC Cancer; 2006 May; 6():136. PubMed ID: 16723013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution to stool DNA testing for colorectal cancer.
    Tagore KS; Levin TR; Lawson MJ
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1225-33. PubMed ID: 15191503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of the p53 gene in the stool of patients with resectable colorectal cancer.
    Eguchi S; Kohara N; Komuta K; Kanematsu T
    Cancer; 1996 Apr; 77(8 Suppl):1707-10. PubMed ID: 8608566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient perceptions of stool-based DNA testing for colorectal cancer screening.
    Schroy PC; Heeren TC
    Am J Prev Med; 2005 Feb; 28(2):208-14. PubMed ID: 15710277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent detection of K-ras mutation in stool samples of colorectal carcinoma patients after improved DNA extraction: comparison with tissue samples.
    Ito Y; Kobayashi S; Taniguchi T; Kainuma O; Hara T; Ochiai T
    Int J Oncol; 2002 Jun; 20(6):1263-8. PubMed ID: 12012008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.
    Bosch LJ; Oort FA; Neerincx M; Khalid-de Bakker CA; Terhaar sive Droste JS; Melotte V; Jonkers DM; Masclee AA; Mongera S; Grooteclaes M; Louwagie J; van Criekinge W; Coupé VM; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
    Cancer Prev Res (Phila); 2012 Mar; 5(3):464-72. PubMed ID: 22135045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for curable colorectal tumors: an approach for the 21st century.
    Stravitz RT; Sanyal AJ
    Am J Gastroenterol; 1993 Jan; 88(1):148-50. PubMed ID: 8420259
    [No Abstract]   [Full Text] [Related]  

  • 19. Methylation changes in faecal DNA: a marker for colorectal cancer screening?
    Müller HM; Oberwalder M; Fiegl H; Morandell M; Goebel G; Zitt M; Mühlthaler M; Ofner D; Margreiter R; Widschwendter M
    Lancet; 2004 Apr; 363(9417):1283-5. PubMed ID: 15094274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates.
    Berger BM; Ahlquist DA
    Pathology; 2012 Feb; 44(2):80-8. PubMed ID: 22198259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.